Thoracic Oncology in the Era of Precision Medicine
A special issue of Clinics and Practice (ISSN 2039-7283).
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 4850
Special Issue Editor
Special Issue Information
Dear Colleagues,
During the past two decades, advances in genomic profiling have allowed for rapid integration of targeted therapies and novel therapies into the systemic management of patients, especially with non-small-cell lung cancer (NSCLC). We learnt how to utilize precision medicine to guide our treatment decisions, especially in NSCLC. Personalized medicine is primarily driven by the advances in genomic testing, biomarker-driven therapy, and immunotherapy that have transformed the landscape of oncology care and have greatly improved outcomes for patients. The application of molecular testing is transforming cancer into a diverse template of genomic alterations that drive oncogenesis. In thoracic oncology, extensive evaluation of genetic alterations has been rewarding in lung cancers, especially adenocarcinomas, now subclassified according to the expression of specific markers, which drive a personalized attempt to cure. In this Special Issue, we aim to collect a wide range of topics in thoracic oncology, including lung cancer, mesothelioma, mediastinal (thymic neoplasms) and rare chest-wall tumors, e.g., solitary fibrous tumors. The contributions can be in the form of original articles, reviews, commentaries and unique and rare case reports.
Dr. Nagla Abdel Karim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Clinics and Practice is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision medicine
- genomic profiling
- immunotherapy
- oncogenesis
- adenocarcinoma
- mesothelioma
- thymic neoplasms and solitary fibrous tumors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
